Browse
We’re here to help

Find guidance on Author Services

Login | Register

Login
Register

Cart Add to Cart

Search
Browse
We’re here to help

Find guidance on Author Services

Home
All Journals
Expert Opinion on Investigational Drugs
List of Issues
Volume 14, Issue 1

Expert Opinion on Investigational Drugs

Search in:

Advanced search Citation search

Citation search

Ready to submit?
Start a new submission or continue a submission in progress
Go to submission site
Instructions for authors
Editorial policies
Editing services site

Journal metrics
Aims & scope
Journal information
Editorial board
News & calls for papers
Advertising information

Latest articles
Current issue
All volumes & issues
Special issues
Open access articles
Most read articles
Most cited articles

New content alerts
RSS

Subscription options & pricing

Buy a subscription

Your download is now in progress and you may close this window

Did you know that with a free Taylor & Francis Online account you can gain access to the following benefits?

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Have an account?
Login now Don't have an account?
Register for free

Login or register to access this feature

Have an account?
Login now Don't have an account?
Register for free

Register a free Taylor & Francis Online account today to boost your research and gain these benefits:

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Register now or learn more

Expert Opinion on Investigational Drugs, Volume 14, Issue 1 (2005)

Browse this journal

Latest articles
Current issue
List of issues
Special issues
Open access articles
Most read articles
Most cited articles

Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days

Expert Opinion on Investigational Drugs, Volume 14, Issue 1 (2005)

See all volumes and issues

Vol 33, 2024 Vol 32, 2023 Vol 31, 2022 Vol 30, 2021 Vol 29, 2020 Vol 28, 2019 Vol 27, 2018 Vol 26, 2017 Vol 25, 2016 Vol 24, 2015 Vol 23, 2014 Vol 22, 2013 Vol 21, 2012 Vol 20, 2011 Vol 19, 2010 Vol 18, 2009 Vol 17, 2008 Vol 16, 2007 Vol 15, 2006 Volume 14, 2005 Vol 13, 2004 Vol 12, 2003 Vol 11, 2002 Vol 10, 2001 Vol 9, 2000 Vol 8, 1999 Vol 7, 1998 Vol 6, 1997 Vol 5, 1996 Vol 4, 1995 Vol 3, 1994

Select to download all citations or PDFs

Download citations Download PDFs Download issue

Browse by section (All)

Display order (Default)
Published online date
Page number
Section A-Z
Most read
Most cited

Review

Review Article

New antiangiogenic strategies for the treatment of proliferative synovitis

Dahlia T Lainer & Ernest Brahn

Pages: 1-17

Published online: 22 Apr 2005

AbstractforNew antiangiogenic strategies for the treatment of proliferative synovitis | References | PDF (1.3 MB)

101 Views
29 CrossRef citations
0Altmetric

Review Article

Drugs to suppress cough

K F Chung

Pages: 19-27

Published online: 22 Apr 2005

AbstractforDrugs to suppress cough | References | PDF (186.7 KB)

359 Views
33 CrossRef citations
0Altmetric

Review Article

Recent advances in the treatment of non-alcoholic fatty liver disease

Flavia D Mendes & Keith D Lindor

Pages: 29-35

Published online: 22 Apr 2005

AbstractforRecent advances in the treatment of non-alcoholic fatty liver disease | References | PDF (134.2 KB)

54 Views
6 CrossRef citations
0Altmetric

Review Article

Nitric oxide and the angiogenic response: can we improve the results of therapeutic angiogenesis?

Varun Kapila, Frank W Sellke, Erik J Suuronen, Thierry G Mesana & Marc Ruel

Pages: 37-44

Published online: 22 Apr 2005

AbstractforNitric oxide and the angiogenic response: can we improve the results of therapeutic angiogenesis? | References | PDF (205 KB)

39 Views
9 CrossRef citations
0Altmetric

Review Article

Thalidomide and immunomodulatory drugs in the treatment of cancer

Aristotle Bamias & Meletios A Dimopoulos

Pages: 45-55

Published online: 22 Apr 2005

AbstractforThalidomide and immunomodulatory drugs in the treatment of cancer | References | PDF (175.5 KB)

90 Views
20 CrossRef citations
0Altmetric

Review Article

Therapeutic assessment of glucagon-like peptide-1 agonists compared with dipeptidyl peptidase IV inhibitors as potential antidiabetic drugs

Rolf Mentlein

Pages: 57-64

Published online: 22 Apr 2005

AbstractforTherapeutic assessment of glucagon-like peptide-1 agonists compared with dipeptidyl peptidase IV inhibitors as potential antidiabetic drugs | References | PDF (163.6 KB)

95 Views
45 CrossRef citations
0Altmetric

Special Report

Article

Rheumatoid disease and the heart: from epidemiology to echocardiography

Gurbir S Bhatia, Michael D Sosin, Karl A Grindulis, Russell C Davis & Gregory YH Lip

Pages: 65-76

Published online: 22 Apr 2005

AbstractforRheumatoid disease and the heart: from epidemiology to echocardiography | References | PDF (180.9 KB)

73 Views
3 CrossRef citations
0Altmetric

Drug Evaluation

Article

Abetimus sodium: a new therapy for delaying the time to, and reducing the incidence of, renal flare and/or major systemic lupus erythematosus flares in patients with systemic lupus erythematosus who have a history of renal disease

Mario H Cardiel

Pages: 77-88

Published online: 22 Apr 2005

AbstractforAbetimus sodium: a new therapy for delaying the time to, and reducing the incidence of, renal flare and/or major systemic lupus erythematosus flares in patients with systemic lupus erythematosus who have a history of renal disease | References | PDF (157.7 KB)

56 Views
14 CrossRef citations
0Altmetric

Miscellaneous

BMS-354825: a novel drug with potential for the treatment of imatinib-resistant chronic myeloid leukaemia

Sheila A Doggrell

Pages: 89-91

Published online: 22 Apr 2005

AbstractforBMS-354825: a novel drug with potential for the treatment of imatinib-resistant chronic myeloid leukaemia | References | PDF (92.3 KB)

121 Views
34 CrossRef citations
0Altmetric

Meeting Report

44th Interscience Conference on Antimicrobial Agents and Chemotherapy: an update on new antibiotics, novel non-antibacterial treatment modalities and critical issues in antibiotic resistance

Michael N Alekshun

Pages: 93-99

Published online: 22 Apr 2005

Abstractfor44th Interscience Conference on Antimicrobial Agents and Chemotherapy: an update on new antibiotics, novel non-antibacterial treatment modalities and critical issues in antibiotic resistance | References | PDF (161.5 KB)

62 Views
3 CrossRef citations
0Altmetric

Explore articles

Latest
Open access
Most read
Most cited
Trending

Explore the most recently published articles

Investigational and emerging gastric inhibitory polypeptide (GIP) receptor-based therapies for the treatment of obesity

Robert H. Gaffey et al.

Review Article | Published online: 17 Jul 2024

Safety, tolerability and pharmacokinetics of ASC10, a novel oral double prodrug of a broad-spectrum antiviral agent, β-d-N4-hydroxycytidine: results from a randomized, double-blind, placebo-controlled phase 1 study in Chinese healthy subjects

Jian Liu et al.

Article | Published online: 12 Jul 2024

Open Access

Medical treatments for abdominal aortic aneurysm: an overview of clinical trials

Jinyi Chen et al.

Review Article | Published online: 11 Jul 2024

Open Access

Emerging treatment landscape for Guillain-Barré Syndrome (GBS): what’s new?

Alina Sprenger-Svačina et al.

Report | Published online: 10 Jul 2024

View all latest articles

Download citations

Choose format

RIS (ProCit, Reference Manager)
BibTeX
RefWorks Direct Export

Download citations

Expert Opinion on Investigational Drugs (Vol.14, Iss.1, 2005)

Access Rights

Only articles that you have access rights to view will be downloaded. The green tick (full access) and orange padlock (open access) icons indicate that you have full access.

Do you want to proceed?